Abstract: Provided are a generation device to reduce launch switching activity, yield loss risk, and power consumption of testing, even in the at-speed scan testing, even with a small number of don't-care (X) bits in input bits as in test compression, without any impact on test data volume, fault coverage, performance, and circuit design, by putting focus on internal lines in the circuit. The generation device includes a target internal line selection unit, a target internal line distinction unit, an identification unit that identifies a bit to be an unspecified bit and a bit to be a logic bit in the input bits, and an assignment unit that assigns a logic value 1 or a logic value 0 to unspecified bits in the input bits. The identification unit includes an unspecified bit identification unit and an input logic bit identification unit.

Abstract: The present invention provides a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior based on craving for addictive substances such as stimulant substances, opioids, barbiturate type anesthetics, hallucinogens, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (?)-1-(Benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior associated with craving for addictive substances.

Abstract: A system for cleaning an object and a method for cleaning an object by irradiating a multiphase fluid containing a gas and liquid droplets, wherein a desired impact force is obtained by controlling the degree of liquid-drop-impact cavitation, which is generated when the liquid droplets in the multiphase fluid hit the object.

Abstract: The present invention provides a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior based on craving for addictive substances such as stimulant substances, opioids, barbiturate type anesthetics, hallucinogens, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (?)-1-(Benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior associated with craving for addictive substances.

Abstract: A staining composition for staining an ophthalmic membrane when performing the ophthalmic membrane removal, wherein the staining composition comprises a Brilliant Blue G (BBG) derivative as a primary component.

Abstract: Methods and compositions for suppressing angiogenesis or neovascularization, as well as methods and compositions that are useful in treatment of a disease or disorder related to angiogenesis or neovascularization. The compositions of the present invention include an effective amount of an ephrinB2, while the methods of the present invention include a step of administering an effective amount of an ephrinB2. The compositions and methods of the present invention is useful in treatment of a disease or disorder related to angiogenesis or neovascularization. The compositions and methods of the present invention may also suppress neovascularization from a retina.

Abstract: A staining composition for staining an ophthalmic membrane when performing the ophthalmic membrane removal, wherein the staining composition comprises a Brilliant Blue G (BBG) derivative as a primary component.